FindTrial
Sign In

Effects of Respiratory Muscle Training in Heart Disease and Sleep Apneia

Effects of Inspiratory Muscle Training in patients with Chronic Heart Failure and Sleep Apneia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3wss27
Enrollment
Unknown
Registered
2018-01-18
Start date
2017-09-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Trained Group - 10 patients (men or woman) with heart failure and sleep apneia. This subjects will perform an nonsupervised inspiratory muscle training program, 30 minutes per day (all days of the wee
Other
E02.190.525.186
E02.760.169.063.500.387

Sponsors

Faculdade de Educação Física e Fisioterapia da Universidade Federal de Uberlândia
Lead Sponsor
Faculdade de Ciências da Saúde da Universidade Metodista de Piracicaba
Collaborator

Eligibility

Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Volunteers with left ventricular ejection fraction> 50%; functional classification of I to III of the disease, according to the New York Heart Association (NYHA); both genders ; aged between 30 and 75 years; non-smokers; non-alcoholic; without chronic obstructive pulmonary disease (FEV1 / FVC> 70% and FEV1> 70% predicted); diagnosed sleep apnea (central apnea / hypopnea index greater than or equal to 5 per hour).

Exclusion criteria

Exclusion criteria: Volunteers with unstable angina; myocardial infarction in the last six months; osteomioarticular, rheumatic and cognitive diseases; systemic arterial hypertension and uncontrolled diabetes.

Design outcomes

Primary

MeasureTime frame
Outcome 1: Improvement of aerobic functional capacity, evaluated by six minute walk test, with inscrease of walked distância of 30 m regarding before intervetion. ;Outcome 2: Improvement inspiratory muscle strength, evaluated by manovacuometry, with increse of 30% of the maximum inspiratory pressure, regarding before intervention.—

Secondary

MeasureTime frame
Outcome 1: Improvement of cardiac parasympathetic autonomic modulation, with increase of high frequency band >0.50 normalized units, evaluated by heart rate variability, regarding before intervention ;Outcome 2: Decrease of cardiac sympathetic autonomic modulation, with decrease of low frequency bandi <0.50 normalized units, evaluated by heart rate variability, regarding before intervention.—

Countries

Brazil

Contacts

Public ContactNayara;Nayara Tamburus;Tamburús

Faculdade de Educação Física e Fisioterapia da Universidade Federal de Uberlândia;Universidade Federal de São Carlos

nayaratamburus@hotmail.com;nayaratamburus@hotmail.com+55 34 3225 8556;+55 16 3306 6705

Outcome results

None listed

Source: REBEC (via WHO ICTRP)